mFOLFOX-6 Clinical Trials
2 recruitingDrug
Phase 22Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Cancer
Parabilis Medicines, Inc.595 enrolled25 locationsNCT05919264
Recruiting
Phase 2
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
Esophagus Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest32 enrolled22 locationsNCT05713838